Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 0 | $0 |
Sells | 14 | $174,902 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
21 Mar 2024 16:41 | CTMX | CytomX Therapeutics Inc | ROWLAND LLOYD A | General Counsel | 19 Mar 2024 | Sale | 5,268 | 2.0855 | 10,986 | D |
21 Mar 2024 16:40 | CTMX | CytomX Therapeutics Inc | MCCARTHY SEAN A. | CEO | 19 Mar 2024 | Sale | 20,223 | 2.0855 | 42,175 | D |
21 Mar 2024 16:38 | CTMX | CytomX Therapeutics Inc | OGDEN CHRISTOPHER | SVP, Finance and Accounting | 19 Mar 2024 | Sale | 2,971 | 2.0855 | 6,196 | D |
21 Mar 2024 16:37 | CTMX | CytomX Therapeutics Inc | BELVIN MARCIA | SVP, Chief Scientific Officer | 19 Mar 2024 | Sale | 12,795 | 2.0855 | 26,684 | D |
21 Mar 2024 16:36 | CTMX | CytomX Therapeutics Inc | LANDAU JEFFREY B | Chief Business Officer | 19 Mar 2024 | Sale | 6,562 | 2.0855 | 13,685 | D |
22 Dec 2023 16:16 | CTMX | CytomX Therapeutics Inc | MCCARTHY SEAN A. | CEO | 20 Dec 2023 | Sale | 13,551 | 1.3807 | 18,710 | D |
22 Dec 2023 16:14 | CTMX | CytomX Therapeutics Inc | BELVIN MARCIA | SVP, Chief Scientific Officer | 20 Dec 2023 | Sale | 4,077 | 1.3805 | 5,628 | D |
22 Dec 2023 16:12 | CTMX | CytomX Therapeutics Inc | LANDAU JEFFREY B | Chief Business Officer | 20 Dec 2023 | Sale | 4,077 | 1.3805 | 5,628 | D |
22 Dec 2023 16:11 | CTMX | CytomX Therapeutics Inc | ROWLAND LLOYD A | General Counsel | 20 Dec 2023 | Sale | 4,077 | 1.3807 | 5,629 | D |
22 Dec 2023 16:10 | CTMX | CytomX Therapeutics Inc | OGDEN CHRISTOPHER | SVP, Finance and Accounting | 20 Dec 2023 | Sale | 1,990 | 1.3806 | 2,747 | D |
22 Sep 2023 19:16 | CTMX | CytomX Therapeutics Inc | BELVIN MARCIA | SVP, Chief Scientific Officer | 22 Sep 2023 | Sale | 4,119 | 1.3003 | 5,356 | D |
22 Sep 2023 19:15 | CTMX | CytomX Therapeutics Inc | LANDAU JEFFREY B | Chief Business Officer | 22 Sep 2023 | Sale | 4,119 | 1.3003 | 5,356 | D |
22 Sep 2023 19:13 | CTMX | CytomX Therapeutics Inc | MCCARTHY SEAN A. | CEO | 22 Sep 2023 | Sale | 14,601 | 1.3004 | 18,987 | D |
22 Sep 2023 19:12 | CTMX | CytomX Therapeutics Inc | ROWLAND LLOYD A | General Counsel | 22 Sep 2023 | Sale | 5,486 | 1.3006 | 7,135 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)